GNRH1 and prostate cancer: Many men with prostate cancer who are unlikely to be able to afford medical treatment with gonadotropin-releasing hormone (GnRH) agonists could benefit from orchiectomy, and training clinician assistants to undertake this cost-effective, easy-to-perform intervention offers substantial potential to improve outcomes.